NASDAQ:APLT

Applied Therapeutics (APLT) Stock Price, News & Analysis

Applied Therapeutics logo
$0.10 0.00 (0.00%)
As of 11/6/2026

About Applied Therapeutics Stock (NASDAQ:APLT)

Advanced

Key Stats

Today's Range
$0.10
▼
$0.10
50-Day Range
$0.10
▼
$0.10
52-Week Range
$0.09
▼
$1.50
Volume
N/A
Average Volume
7.28 million shs
Market Capitalization
$15.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00
Consensus Rating
Reduce

Company Overview

Applied Therapeutics is a biotechnology company focused on developing small-molecule medicines for rare metabolic and other serious diseases. Founded in 2016, the company is based in New York and was founded by Shoshana Shendelman, who has served as its chief executive officer.

The company’s pipeline has centered on govorestat, an investigational inhibitor of the enzyme aldose reductase. Applied Therapeutics has studied the drug in conditions including classic galactosemia, SORD deficiency and PMM2-CDG, disorders that can affect multiple body systems and have limited treatment options.

Applied Therapeutics has also pursued drug development in other disease areas. Its programs are investigational; the company’s work has focused on clinical research and development rather than marketing an established portfolio of approved medicines.

AI Generated. May Contain Errors.

Receive APLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APLT Stock News Headlines

Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
See More Headlines

APLT Stock Analysis - Frequently Asked Questions

Applied Therapeutics' stock was trading at $0.10 at the beginning of 2026. Since then, APLT shares have increased by 3.0% and is now trading at $0.1030.

Applied Therapeutics Inc. (NASDAQ:APLT) announced its quarterly earnings results on Thursday, November, 13th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. The company had revenue of $1 million for the quarter, compared to analysts' expectations of $250 thousand.

Applied Therapeutics (APLT) raised $60 million in an initial public offering on the week of May 13th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and UBS Investment Bank acted as the underwriters for the IPO and Baird was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Viking Therapeutics (VKTX), Nikola (NKLAQ), AT&T (T) and NIO (NIO).

Company Calendar

Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:APLT
CIK
1697532
Fax
N/A
Employees
30
Year Founded
2017

Price Target and Rating

High Price Target
$1.00
Low Price Target
$1.00
Potential Upside/Downside
+870.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$105.62 million
Net Margins
N/A
Pretax Margin
-1,813.80%
Return on Equity
-340.84%
Return on Assets
-175.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.96
Quick Ratio
0.96

Sales & Book Value

Annual Sales
$1 million
Price / Sales
15.86
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.49 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
153,958,000
Free Float
151,495,000
Market Cap
$15.86 million
Optionable
Optionable
Beta
2.08

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:APLT) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners